Abstract
ObjectivesTo compare the incidence of serious infection (SI) across biologic drugs used to treat rheumatoid arthritis (RA) using data from the British Society for Rheumatology Biologics Register for Rheumatoid Arthritis...
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have